2021. Portal hypertension after prolonged use of trastuzumab emtansine: nodular regenerative hyperplasia with autoimmune features. Research, Society and Development. 10, 8 (Jul. 2021), e10810817005. DOI:https://doi.org/10.33448/rsd-v10i8.17005.